iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/38791104/
Vitamin Status in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 7;25(10):5065.
doi: 10.3390/ijms25105065.

Vitamin Status in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis

Kamila Bokayeva  1 , Małgorzata Jamka  1 , Dariusz Walkowiak  2 , Monika Duś-Żuchowska  1 , Karl-Heinz Herzig  1   3 , Jarosław Walkowiak  1
Affiliations
Review

Vitamin Status in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis

Kamila Bokayeva et al. Int J Mol Sci. .

Abstract

The published data on the vitamin status of patients with phenylketonuria (PKU) is contradictory; therefore, this systematic review and meta-analysis evaluated the vitamin status of PKU patients. A comprehensive search of multiple databases (PubMed, Web of Sciences, Cochrane, and Scopus) was finished in March 2024. The included studies compared vitamin levels between individuals diagnosed with early-treated PKU and healthy controls while excluding pregnant and lactating women, untreated PKU or hyperphenylalaninemia cases, control groups receiving vitamin supplementation, PKU patients receiving tetrahydrobiopterin or pegvaliase, and conference abstracts. The risk of bias in the included studies was assessed by the Newcastle-Ottawa scale. The effect sizes were expressed as standardised mean differences. The calculation of effect sizes with 95% CI using fixed-effects models and random-effects models was performed. A p-value < 0.05 was considered statistically significant. The study protocol was registered in the PROSPERO database (CRD42024519589). Out of the initially identified 11,086 articles, 24 met the criteria. The total number of participants comprised 770 individuals with PKU and 2387 healthy controls. The meta-analyses of cross-sectional and case-control studies were conducted for vitamin B12, D, A, E, B6 and folate levels. PKU patients demonstrated significantly higher folate levels (random-effects model, SMD: 1.378, 95% CI: 0.436, 2.320, p = 0.004) and 1,25-dihydroxyvitamin D concentrations (random-effects model, SMD: 2.059, 95% CI: 0.250, 3.868, p = 0.026) compared to the controls. There were no significant differences in vitamin A, E, B6, B12 or 25-dihydroxyvitamin D levels. The main limitations of the evidence include a limited number of studies and their heterogeneity and variability in patients' compliance. Our findings suggest that individuals with PKU under nutritional guidance can achieve a vitamin status comparable to that of healthy subjects. Our study provides valuable insights into the nutritional status of PKU patients, but further research is required to confirm these findings and explore additional factors influencing vitamin status in PKU.

Keywords: PKU; diet therapy; meta-analysis; metabolism; nutrition; phenylketonuria; vitamin status; vitamins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA 2020 flow diagram.
Figure 2
Figure 2
Forest plot of the folate levels in PKU patients (favours A) vs. controls (favours B) (random model) [26,27,39,42,43,44,46,48,49]. CI—confidence interval; Std—standard; Std diff—standard differences.
Figure 3
Figure 3
Forest plot of vitamin B12 levels in PKU patients (favours A) vs. controls (favours B) (random model) [26,27,39,42,43,44,49]. CI—confidence interval; Std—standard; Std diff—standard differences.
Figure 4
Figure 4
Forest plot of vitamin D levels in PKU patients (favours A) vs. controls (favours B) (random model) [29,30,31,39,41,47,50]. CI—confidence interval; Std—standard; Std diff—standard differences.
Figure 5
Figure 5
Forest plot of 1,25-dihydroxyvitamin D levels in PKU patients (favours A) vs. controls (favours B) (random model) [29,30,50]. CI—confidence interval; Std—standard; Std diff—standard differences.
Figure 6
Figure 6
Forest plot of vitamin A levels in PKU patients (favours A) vs. controls (favours B) (random model) [28,31,32]. CI—confidence interval; Std—standard; Std diff—standard differences.
Figure 7
Figure 7
Forest plot of the vitamin E levels in PKU patients (favours A) vs. controls (favours B) (random model) [25,28,31,32,45,53]. CI—confidence interval; Std—standard; Std diff—standard differences.
Figure 8
Figure 8
Forest plot of vitamin B6 levels in PKU patients (favours A) vs. controls (favours B) (random model) [27,38]. CI—confidence interval; Std—standard; Std diff—standard differences.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Al Hafid N., Christodoulou J. Phenylketonuria: A Review of Current and Future Treatments. Transl. Pediatr. 2015;4:304–317. doi: 10.3978/j.issn.2224-4336.2015.10.07. - DOI - PMC - PubMed
    1. Hillert A., Anikster Y., Belanger-Quintana A., Burlina A., Burton B.K., Carducci C., Chiesa A.E., Christodoulou J., Đorđević M., Desviat L.R., et al. The Genetic Landscape and Epidemiology of Phenylketonuria. Am. J. Hum. Genet. 2020;107:234–250. doi: 10.1016/j.ajhg.2020.06.006. - DOI - PMC - PubMed
    1. Flydal M.I., Martinez A. Phenylalanine Hydroxylase: Function, Structure, and Regulation. IUBMB Life. 2013;65:341–349. doi: 10.1002/iub.1150. - DOI - PubMed
    1. Blau N., van Spronsen F.J., Levy H.L. Phenylketonuria. Lancet. 2010;376:1417–1427. doi: 10.1016/S0140-6736(10)60961-0. - DOI - PubMed
    1. Bickel H., Gerrard J., Hickmans E.M. Influence of Phenylalanine Intake on Phenylketonuria. Lancet. 1953;265:812–813. doi: 10.1016/s0140-6736(53)90473-5. - DOI - PubMed

Grants and funding

This research received no external funding.